GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Darwin AG (XTER:7V0) » Definitions » Capital Expenditure

Darwin AG (XTER:7V0) Capital Expenditure : €-1.45 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Darwin AG Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Darwin AG's cash flow for capital expenditures for the six months ended in Dec. 2023 was €-1.45 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.45 Mil.


Darwin AG Capital Expenditure Historical Data

The historical data trend for Darwin AG's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Darwin AG Capital Expenditure Chart

Darwin AG Annual Data
Trend Dec21 Dec22 Dec23
Capital Expenditure
-0.89 -2.61 -1.45

Darwin AG Semi-Annual Data
Dec21 Dec22 Dec23
Capital Expenditure -0.89 -2.61 -1.45

Darwin AG Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Darwin AG Business Description

Traded in Other Exchanges
Address
Brienner Strasse 7, Munich, BY, DEU, D-80333
Darwin AG is a biotechnology company. It is engaged in the field of human genetics. The group also develops and sells personalized dietary supplements and cosmetics. Its brand includes Novodaily; Rootine and Genopedia.

Darwin AG Headlines

No Headlines